We had recommended MCX in Volume No 34 Issue No 1 (dated Oct. 23, 2017) when the scrip was trading at Rs 1110. Our recommendation was based on fundamental and technical factors. The Q3FY18 numbers are out and the company's revenue de-grew by 11.2 per cent YoY while operating profit and net profit declined by 29.8 per cent and 44.7 per cent, respectively. The ADT in commodity futures decreased by 3.7 per cent YoY,